Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP

Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-10 · accession 0001209191-23-018446 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-03-14	2023-03-11	IART	De Witte Jan	Pres, CEO, Dir	F - Tax	$52.87	-3,842	5,006	-43%	-$203.1K
DM	2023-03-14	2023-03-10	IART	De Witte Jan	Pres, CEO, Dir	A - Grant	$0.00	+89.7K	63.7K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-11	F	D	3,842	$52.87	5,006	D	—	—
2	Derivative	Restricted Stock Units	2023-03-10	A	A	26,008	$0.00	100,033	D	$0.00 · — to —	26,008 Common Stock	(F2) The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/10/2023 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.
3	Derivative	Non-Qualified Stock Option (right to buy)	2023-03-10	A	A	63,717	$0.00	63,717	D	$52.87 · — to 2031-03-10	63,717 Common Stock	(F1) 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023.